GE Healthcare

Princeton, New Jersey 08844

0 studies enrolling now · 29 studies all time

What they study most

Alzheimer's Disease, Brain Fibrillarab Levels, Breast Cancer, Carotid Artery Disease, Chronic Kidney Disease, Chronic Renal Insufficiency, Cognitive Impairment, Congestive Heart Failure, Coronary Artery Disease, Coronary Artery Disease (CAD), Diabete Mellitus, Diabetes Mellitus

Studies at this site

• Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma — Completed
• A Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT — Stopped early
• Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography — Withdrawn before enrolling
• Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure — Completed
• Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease — Completed
• Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event — Completed
• Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up. — Completed
• Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem — Completed
• Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease — Completed
• Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView. — Completed
• Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care — Completed
• Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography — Stopped early
• Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease — Completed
• Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI) — Completed
• Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography — Completed
• Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers — Completed
• Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease — Stopped early
• Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction — Stopped early
• Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis — Completed
• Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus — Stopped early
• Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels — Completed
• Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects — Completed
• A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms — Completed
• A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice. — Completed
• PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus — Completed
• Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT) — Completed
• Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram — Completed
• Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma — APPROVED_FOR_MARKETING
• Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches — Completed